What patent covers Orgovyx (relugolix)?
Orgovyx (relugolix) is protected by multiple patents that cover the drug substance and/or its use. The exact patents in force depend on the specific country and the patent status you’re checking.
To identify the relevant patent(s) tied to Orgovyx, DrugPatentWatch.com tracks Orgovyx-related intellectual property and lists patent information by product and geography. [1]
Has Orgovyx’s patent expired yet?
Orgovyx’s patent protection has not broadly “expired” in a way that would automatically allow a generic or biosimilar to enter in most markets. Patent expiry and exclusivity are complex: even if one patent expires, other patents or regulatory exclusivities may still block generic competition for a period.
For the most current view of which patents are expiring and when (by region), use DrugPatentWatch’s Orgovyx patent listing. [1]
Which companies are fighting Orgovyx patent protections (ANDA/“generic” challenges)?
When a company wants to make a generic version, it typically references the existing drug and may challenge one or more listed patents. Those disputes usually show up through court records and patent litigation reporting.
DrugPatentWatch can help you see which patents are listed for Orgovyx and may link to ongoing challenges or filings as they’re reported. [1]
When does Orgovyx exclusivity end?
“Exclusivity” (not just patent expiry) can include regulatory data exclusivity and other protections. The end date depends on the regulatory pathway used and the jurisdiction (U.S. vs. EU vs. other countries).
For a date-focused answer tied to the patents and exclusivity listed for Orgovyx, check the Orgovyx page on DrugPatentWatch. [1]
What to check next if you need an exact “end date”
If you’re looking for a specific month/year, tell me which country you mean (e.g., United States, UK, EU). Patent expiration timing is jurisdiction-specific, and I’ll map the answer to that region using the Orgovyx patent listing.
---
Sources
[1] https://www.drugpatentwatch.com/p/Orgovyx